Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $21.1800 (-3.73%) ($20.7700 - $21.9100) on Thu. May. 23, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.96% (three month average) | RSI | 34 | Latest Price | $21.1800(-3.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.8% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(60%) XBI(59%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -1.98% in a week (0% probabilities). VXX(-17%) VIXM(-7%) UUP(-6%) TLT(-4%) IFRA(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.98% (StdDev 3.96%) | Hourly BBV | 0 () | Intraday Trend | -2.2% | | | |
|
1 - 5 Day Possible Target | $8.23(-61.14%) | Resistance Level | $23.73 | 5 Day Moving Average | $22.02(-3.81%) | 10 Day Moving Average | $22.48(-5.78%) | 20 Day Moving Average | $23.73(-10.75%) | To recent high | -23.7% | To recent low | 2.7% | Market Cap | $1.315b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |